Učitavanje...
The Road to Better Management in Resistant Hypertension—Diagnostic and Therapeutic Insights
Resistant hypertension (R-HTN) implies a higher mortality and morbidity compared to non-R-HTN due to increased cardiovascular risk and associated adverse outcomes—greater risk of developing chronic kidney disease, heart failure, stroke and myocardial infarction. R-HTN is considered when failing to l...
Spremljeno u:
| Izdano u: | Pharmaceutics |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8153016/ https://ncbi.nlm.nih.gov/pubmed/34068168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13050714 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|